Clia Waived Hemoglobin A1c

PHYSICIANS MAY EARN PAY BOOST OF UP TO 5.1 PERCENT FROM MIPPA UPDATE PLUS E-PRESCRIBING AND PQRI INCENTIVES
Read Full Article »

Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD
Read Full Article »

Chemokine Protein CXCR3 Receptor Found in Celiac Disease
Read Full Article »

Incentives to e-Prescribe
Read Full Article »

Silent Stroke Affects 10 Percent of Healthy Middle-Aged Patients
Read Full Article »

Home --> Diagnostics --> CLIA-Waived Diagnostic Devices --> CLIA-Waived Hemoglobin A1c -->

CLIA-WAIVED HEMOGLOBIN A1C

CLIA-waived hemoglobin A1c refers medical equipment that tests diabetic patients’ blood for hemoglobin that has a glucose molecule attached to it. CLIA-waived hemoglobin A1c is used to monitor the long-term blood glucose status of diabetic patients as a means of determining adequacy of treatment of the patients’ diabetes mellitus.

CLIA stands for “Clinical Laboratory Improvement Amendments.” This is a group of regulations promulgated by the U.S. Food and Drug Administration (FDA) that set clinical laboratory testing standards. CLIA-waived refers to testing devices that are simple in operation and have been cleared by the FDA for use by existing physician office staff.

<< Go To Top >>

Check All \| Uncheck All
		Hemoglbin A1c Test InView (20 Disposable Tests) Hemoglobin A1c Test, blood glucose A1c Now. InView test provides quantitative measurement of the percent of glycated hemoglobin (A1c) levels in capillary (fingerstick) or venous whole blood samples. The test is for prof. use to monitor glycemic control in people with diabetes-Hemoglobin A1c Test InView....

Check All \| Uncheck All